04.18.16
Green Biologics, Inc., the U.S. subsidiary of Green Biologics Ltd., a U.K. industrial biotechnology and renewable chemicals company, has announced a distribution agreement with Acme-Hardesty, a division of Jacob Stern & Sons, Inc. and a U.S. supplier of bio-based chemicals. Acme-Hardesty will focus its efforts on marketing Green Biologics’ renewable n-butanol and acetone for high value applications in food ingredients, cleaning products and bio-lubricants.
“We’re pleased to announce this partnership with Acme-Hardesty,” said Timothy G. Staub, Global Vice President of Business Development for Green Biologics. “Acme-Hardesty’s history in sustainable chemistry reaches back to the 1880s with Jacob Stern & Sons, and we’re delighted to align Green Biologics with this outstanding industry leader.”
Using a proprietary fermentation platform, Green Biologics is able to produce higher quality chemicals that are molecularly identical to their petro-based counterparts without the associated contaminants produced through traditional routes. Compared to traditional fermentation platforms, the Green Biologics platform can significantly reduce both the production cost and the capital cost of implementation.
The company’s first commercial production facility for renewable n-butanol and acetone is currently being constructed in Little Falls, Minnesota. Start-up of operations at the plant is scheduled for later this year, with shipments to customers anticipated by Q4 2016. Additionally, as part of its commitment to green chemistry, Green Biologics is a proud member of the American Chemistry Council (ACC) and an active participant in its Responsible Care initiative.
“We’re focused on identifying and securing opportunities in markets that can leverage the value and benefit from the performance of our sustainable products,” added Staub. “Acme-Hardesty’s commitment to providing sustainable technology solutions mirrors our own, and we’re excited to join forces to meet the needs of these high value markets.”
“We believe in the power of bio-based ingredients and are pleased to be a channel partner with Green Biologics,” said Karen Graziano, Director of Advanced Renewables Development for Acme-Hardesty. “It is an exciting opportunity to work with Green Biologics and together advance the commercial viability of these unique renewable materials.”
“We’re pleased to announce this partnership with Acme-Hardesty,” said Timothy G. Staub, Global Vice President of Business Development for Green Biologics. “Acme-Hardesty’s history in sustainable chemistry reaches back to the 1880s with Jacob Stern & Sons, and we’re delighted to align Green Biologics with this outstanding industry leader.”
Using a proprietary fermentation platform, Green Biologics is able to produce higher quality chemicals that are molecularly identical to their petro-based counterparts without the associated contaminants produced through traditional routes. Compared to traditional fermentation platforms, the Green Biologics platform can significantly reduce both the production cost and the capital cost of implementation.
The company’s first commercial production facility for renewable n-butanol and acetone is currently being constructed in Little Falls, Minnesota. Start-up of operations at the plant is scheduled for later this year, with shipments to customers anticipated by Q4 2016. Additionally, as part of its commitment to green chemistry, Green Biologics is a proud member of the American Chemistry Council (ACC) and an active participant in its Responsible Care initiative.
“We’re focused on identifying and securing opportunities in markets that can leverage the value and benefit from the performance of our sustainable products,” added Staub. “Acme-Hardesty’s commitment to providing sustainable technology solutions mirrors our own, and we’re excited to join forces to meet the needs of these high value markets.”
“We believe in the power of bio-based ingredients and are pleased to be a channel partner with Green Biologics,” said Karen Graziano, Director of Advanced Renewables Development for Acme-Hardesty. “It is an exciting opportunity to work with Green Biologics and together advance the commercial viability of these unique renewable materials.”
